Vrirose-F Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Fenofibrate (160mg) + Rosuvastatin (10mg)
Overview Vrirose-F Tablet
LipiComb tablets combine two lipid-reducing agents to lower elevated cholesterol and triglyceride levels in the blood. Prescribed when dietary modifications (like a low-fat diet) prove insufficient, LipiComb helps mitigate the risk of cardiovascular disease. Administration is flexible—with or without food—but consistent daily timing improves adherence. Dosage is personalized, based on individual lipid profiles and treatment response. While high cholesterol and triglycerides often present without symptoms, discontinuing LipiComb can worsen the condition and increase stroke and heart disease risks. Regular lipid profile monitoring is crucial. This medication complements a comprehensive treatment plan incorporating a healthy diet low in fat, regular physical activity, smoking cessation, moderate alcohol consumption, and weight management. While maintaining a normal diet, minimizing high-fat foods is recommended. Common, typically mild and transient, side effects include nausea, abdominal discomfort, constipation, headache, flatulence, and myalgia. Persistent side effects, jaundice, unusual bleeding or bruising, or severe or unexplained muscle pain necessitate immediate medical attention. Periodic liver function tests may be advised. LipiComb is contraindicated in liver disease (e.g., abnormal liver function tests, persistent jaundice). Kidney issues, pregnancy, pregnancy planning, or breastfeeding should be disclosed to your physician before commencing treatment. Diabetic patients should closely monitor their blood glucose levels, as LipiComb may elevate blood sugar.
Primary Ingredients of Vrirose-F Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vrirose-F Tablet
Cardiovascular event prevention and hypercholesterolemia management
Major Benefits of Vrirose-F Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Vrirose-F Tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Vrirose-F Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Vrirose-F Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Vrirose-F Tablet can be ingested with or without food, however, consistent timing is recommended.
How Vrirose-F Tablet works:
Lipitor-F combines fenofibrate and rosuvastatin to reduce elevated lipids. Fenofibrate decreases blood triglyceride levels, and rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol, the harmful type. Concurrently, both medications increase high-density lipoprotein (HDL) cholesterol, the beneficial type.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Vrirose-F Tablet should not be taken together.
PregnancyUNSAFE
Using Vrirose-F tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician immediately, as research in both animals and humans has revealed considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Vrirose-F Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vrirose-F Tablet.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Vrirose-F Tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Vrirose-F Tablets; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Vrirose-F Tablets, as dose modification may be necessary. Consult a physician before use. Vrirose-F Tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Vrirose-F Tablet :
Should you forget a Vrirose-F Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Vrirose-F Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently